Phase I study of adjuvant immunotherapy using donor liver derived NK cells for preventing HCC recurrence after liver transplantationY. Imaoka,K. Sato,K. Imaoka,N. Tanimine,H. Tahara,K. Ide,T. Kobayashi, Y. Tanaka,A. Tzakis,S. Nishida,H. Ohdan,M. OhiraTRANSPLANTATION(2022)引用 0|浏览24暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要